<?xml version="1.0" encoding="UTF-8"?>
<table xmlns="http://www.w3.org/1999/xhtml">
 <thead>
  <caption>PMC6129014</caption>
  <tr>
   <th>label</th>
   <th>caption</th>
  </tr>
 </thead>
 <tbody>
  <tr>
   <td>Figure 1</td>
   <td>DCEO inhibited the production of NO and PGE2 and the express ... </td>
  </tr>
  <tr>
   <td>Figure 2</td>
   <td>DCEO reduced the production of cytokines and chemokines in L ... </td>
  </tr>
  <tr>
   <td>Figure 3</td>
   <td>DCEO decreased mRNA levels of cytokines and chemokines in LP ... </td>
  </tr>
  <tr>
   <td>Figure 4</td>
   <td>DCEO affected the molecular components of the IRAK/NF-κB, IR ... </td>
  </tr>
  <tr>
   <td>Figure 5</td>
   <td>DCEO modulates the molecular components of the IRAK/NF-κB, I ... </td>
  </tr>
  <tr>
   <td>Figure 6</td>
   <td>DCEO inhibited nuclear localization of NF-κB, AP-1, and IRF3 ... </td>
  </tr>
  <tr>
   <td>Figure 7</td>
   <td>DCEO inhibited nuclear localization of NF-κB in LPS-stimulat ... </td>
  </tr>
  <tr>
   <td>Figure 8</td>
   <td>A schematic diagram showing the association of IRAK/NF-κB, I ... </td>
  </tr>
 </tbody>
</table>
